申请人:Meiji Seika Kaisha Ltd.
公开号:US20030119787A1
公开(公告)日:2003-06-26
A compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof:
1
wherein R
1
represents hydrogen atom, an alkyl group, a substituted alkyl group and the like; R
2
and R
3
represent hydrogen atom, an alkyl group, a substituted alkyl group, an alkoxyl group and the like; X represents —CH
2
—, —O—, or —NH—; A represents the following group (II):
2
[in which R
7
and R
8
represent hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group and the like; R
9
and R
10
represents hydrogen atom, a halogen atom, hydroxyl group, phenyl group, an alkyl group and the like] and the like; and E represents hydrogen atom and the like, which has inhibitory activity against carboxypeptidase B and is useful for therapeutic and/or preventive treatment of a thrombotic disease.
以下是通用式(I)及其药学上可接受的盐所代表的化合物:其中R1代表氢原子、烷基、取代烷基等;R2和R3代表氢原子、烷基、取代烷基、烷氧基等;X代表—CH2—、—O—或—NH—;A代表以下基团(II):其中R7和R8代表氢原子、烷基、酰基、烷氧羰基等;R9和R10代表氢原子、卤素原子、羟基、苯基、烷基等;E代表氢原子等,具有对羧肽酶B的抑制活性,可用于治疗和/或预防血栓性疾病。